- Zen Leaf Wynnewood is conveniently located off U.S. Route 30 at 257 Lancaster Avenue, a thoroughfare that sees an average daily traffic count of 25,000 vehicles, according to the Pennsylvania Department of Transportation
- Verano’s active operations span 13 states, comprised of 100 affiliated dispensaries and 13 cultivation and processing facilities with more than 1 million square feet of cultivation capacity
CHICAGO, June 03, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its 100th affiliated dispensary in the nation, Zen Leaf Wynnewood, will open on Friday, June 3 at 9 a.m. through permitee NSE Pennsylvania, LLC. Located at 257 Lancaster Avenue, Zen Leaf Wynnewood is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 10 a.m. to 6 p.m., local time.
Zen Leaf Wynnewood is located just outside of Philadelphia in Montgomery County, the third most populous county in Pennsylvania. Montgomery County experienced a population increase of 7% from 2010 to 20201.
“Reaching the milestone of operating 100 dispensaries nationwide is a result of the incredible dedication of our Verano team and the enduring loyalty of our valued customers,” said George Archos, Verano Founder and Chief Executive Officer. “We’re forever grateful to all our guests and team members for their support throughout this exciting journey, and look forward to celebrating this historic day in the great state of Pennsylvania by serving medical patients at our brand new Zen Leaf dispensary in Wynnewood.”
Zen Leaf Wynnewood will offer a suite of cannabis therapeutics, including flower, topicals, and vapes. For additional convenience and accessibility, patients can choose to order ahead at zenleaf.com for express in-store or curbside pickup. For more information about Zen Leaf medical cannabis dispensary, visit zenleaf.com.
About Verano
Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, Encore™, and MÜV™. Verano’s portfolio encompasses 15 U.S. states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.
Contacts:
Media
Verano
Grace Bondy
Manager, Communications
Grace.Bondy@verano.com
517-672-8001
Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
Julianna.Paterra@verano.com
Forward Looking Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", “future”, "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements or information with respect to the Company’s operations. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risk factors discussed in the Company's publicly available filings on SEDAR at www.sedar.com. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
###
1 Source: U.S. Census
